Hendriks’ team introduces the FatTracer, a CRISPR screening platform designed to identify steatosis modulators and potential targets using APOB−/− and MTTP−/− organoids and identified fatty acid desaturase 2 (FADS2) as a key factor in hepatic steatosis. This evidence concerns the gene FADS2 and fatty liver disease.